Your browser doesn't support javascript.
loading
Molecular signaling pathways underlying schizophrenia.
Tiihonen, Jari; Koskuvi, Marja; Lähteenvuo, Markku; Trontti, Kalevi; Ojansuu, Ilkka; Vaurio, Olli; Cannon, Tyrone D; Lönnqvist, Jouko; Therman, Sebastian; Suvisaari, Jaana; Cheng, Lesley; Tanskanen, Antti; Taipale, Heidi; Lehtonen, Sárka; Koistinaho, Jari.
Afiliación
  • Tiihonen J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Center for Psychiatry Research, Stockholm City Council, Stockholm, Sweden; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland. Electronic address: jari.tiihonen@ki.se.
  • Koskuvi M; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland; Neuroscience Center, University of Helsinki, Helsinki, Finland.
  • Lähteenvuo M; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
  • Trontti K; SleepWell Research Program and Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Ojansuu I; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
  • Vaurio O; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
  • Cannon TD; Department of Psychology and Psychiatry, Yale University, New Haven, CT, USA.
  • Lönnqvist J; Mental Health Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland; Department of Psychiatry, University of Helsinki, Helsinki, Finland.
  • Therman S; Mental Health Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
  • Suvisaari J; Mental Health Unit, Department of Public Health Solutions, National Institute for Health and Welfare, Helsinki, Finland.
  • Cheng L; Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.
  • Tanskanen A; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland.
  • Taipale H; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Kuopio, Finland; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
  • Lehtonen S; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland; Neuroscience Center, University of Helsinki, Helsinki, Finland.
  • Koistinaho J; A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland; Neuroscience Center, University of Helsinki, Helsinki, Finland.
Schizophr Res ; 232: 33-41, 2021 06.
Article en En | MEDLINE | ID: mdl-34010744
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esquizofrenia Tipo de estudio: Prognostic_studies País/Región como asunto: Europa Idioma: En Revista: Schizophr Res Asunto de la revista: PSIQUIATRIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Esquizofrenia Tipo de estudio: Prognostic_studies País/Región como asunto: Europa Idioma: En Revista: Schizophr Res Asunto de la revista: PSIQUIATRIA Año: 2021 Tipo del documento: Article